Deutsche Bank’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,700
| Closed | -$135K | – | 4627 |
|
|
2021
Q2 | $135K | Buy |
1,700
+1,252
| +279% | +$99.4K | ﹤0.01% | 3945 |
|
|
2021
Q1 | $59K | Sell |
448
-40
| -8% | -$5.27K | ﹤0.01% | 4101 |
|
|
2020
Q4 | $77K | Buy |
488
+121
| +33% | +$19.1K | ﹤0.01% | 3906 |
|
|
2020
Q3 | $39K | Buy |
367
+33
| +10% | +$3.51K | ﹤0.01% | 3915 |
|
|
2020
Q2 | $40K | Buy |
334
+122
| +58% | +$14.6K | ﹤0.01% | 3850 |
|
|
2020
Q1 | $16K | Sell |
212
-13
| -6% | -$981 | ﹤0.01% | 3862 |
|
|
2019
Q4 | $65K | Buy |
225
+50
| +29% | +$14.4K | ﹤0.01% | 3733 |
|
|
2019
Q3 | $30K | Sell |
175
-227
| -56% | -$38.9K | ﹤0.01% | 4022 |
|
|
2019
Q2 | $158K | Sell |
402
-248
| -38% | -$97.5K | ﹤0.01% | 3862 |
|
|
2019
Q1 | $303K | Buy |
650
+1
| +0.2% | +$466 | ﹤0.01% | 3687 |
|
|
2018
Q4 | $311K | Sell |
649
-628
| -49% | -$301K | ﹤0.01% | 3552 |
|
|
2018
Q3 | $869K | Buy |
1,277
+243
| +24% | +$165K | ﹤0.01% | 3404 |
|
|
2018
Q2 | $706K | Buy |
+1,034
| New | +$706K | ﹤0.01% | 3598 |
|